Characterization of NFE2L1-616, an isoform of nuclear factor-erythroid-2 related transcription factor-1 that activates antioxidant response element-regulated genes

被引:0
|
作者
Daniel V. Ho
Kaylen G. Suryajaya
Kaitlyn Manh
Amanda N. Duong
Jefferson Y. Chan
机构
[1] University of California,Department of Laboratory Medicine and Pathology
[2] Irvine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The NFE2L1 transcription factor (aka Nrf1) is a basic leucine zipper protein that performs a critical role in the cellular stress response pathway. Here, we characterized a novel variant of NFE2L1 referred to as NFE2L1-616. The transcript encoding NFE2L1-616 is derived from an intronic promoter, and it has a distinct first exon than other reported full-length NFE2L1 isoforms. The NFE2L1-616 protein constitutively localizes in the nucleus as it lacks the N-terminal amino acid residues that targets other full-length NFE2L1 isoforms to the endoplasmic reticulum. The expression level of NFE2L1-616 is lower than other NFE2L1 isoforms. It is widely expressed across different cell lines and tissues that were examined. NFE2L1-616 showed strong transcriptional activity driving luciferase reporter expression from a promoter containing antioxidant response element. Together, the results suggest that NFE2L1-616 variant can function as a positive regulator in the transcriptional regulation of NFE2L1 responsive genes.
引用
收藏
相关论文
共 50 条
  • [1] Characterization of NFE2L1-616, an isoform of nuclear factor-erythroid-2 related transcription factor-1 that activates antioxidant response element-regulated genes
    Ho, Daniel V.
    Suryajaya, Kaylen G.
    Manh, Kaitlyn
    Duong, Amanda N.
    Chan, Jefferson Y.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [2] Characterization of Nrf1b, a Novel Isoform of the Nuclear Factor-Erythroid-2 Related Transcription Factor-1 That Activates Antioxidant Response Element-Regulated Genes
    Kwong, Eric K.
    Kim, Kyung-Mi
    Penalosa, Patrick J.
    Chan, Jefferson Y.
    PLOS ONE, 2012, 7 (10):
  • [3] Nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) is regulated by O-GlcNAc transferase
    Han, Jeong Woo
    Valdez, Joshua L.
    Ho, Daniel V.
    Lee, Candy S.
    Kim, Hyun Min
    Wang, Xiaorong
    Huang, Lan
    Chan, Jefferson Y.
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 110 : 196 - 205
  • [4] Glycogen synthase kinase 3 regulates expression of nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) and inhibits pro-survival function of Nrf1
    Biswas, Madhurima
    Kwong, Erick K.
    Park, Eujean
    Nagra, Parminder
    Chan, Jefferson Y.
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (13) : 1922 - 1931
  • [5] Nuclear Factor Erythroid-2 Like 1 (NFE2L1): Structure, function and regulation
    Kim, Hyun Min
    Han, Jeong Woo
    Chan, Jefferson Y.
    GENE, 2016, 584 (01) : 17 - 25
  • [6] Characterization of tangeretin as an activator of nuclear factor erythroid 2-related factor 2/antioxidant response element pathway in HEK293T cells
    Lv, Chengyu
    Li, Yuqiu
    Liang, Rong
    Huang, Wei
    Xiao, Yechen
    Ma, Xinqi
    Wang, Yongjun
    Zou, Haoyang
    Qin, Fen
    Sun, Chang
    Li, Tiezhu
    Zhang, Jie
    CURRENT RESEARCH IN FOOD SCIENCE, 2023, 6
  • [7] Nuclear Factor (Erythroid-Derived 2)-Like-1 (NFE2L1): At the Crossroads of Stress Responses
    Willmore, William G.
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : S47 - S47
  • [8] High throughput resequencing to characterize age associated changes in nuclear factor erythroid 2 related factor 2 and the antioxidant response element interactions
    Smith, Eric Jonathan
    Hagen, Tory M.
    FASEB JOURNAL, 2009, 23
  • [9] Activation of the nuclear factor erythroid 2-related factor 2-antioxidant response element signal in rats with diffuse axonal injury
    Gao, Peng
    Zhou, Mengliang
    Ouyang, Yiming
    Wang, Handong
    NEUROREPORT, 2019, 30 (06) : 389 - 396
  • [10] Therapeutic Potential of the Activators of the Nuclear Factor Erythroid 2-Related Factor 2-Antioxidant Response Element Pathway in Brain Disorders
    Kume, Toshiaki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (05) : 553 - 556